Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 996

1.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P.

Eur J Cancer. 2004 Oct;40(15):2201-16. Review.

PMID:
15454245
[PubMed - indexed for MEDLINE]
2.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.

PMID:
17182241
[PubMed - indexed for MEDLINE]
3.

Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.

Nowrousian MR.

Med Oncol. 1998 Aug;15 Suppl 1:S19-28. Review.

PMID:
9785333
[PubMed - indexed for MEDLINE]
4.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
[PubMed - indexed for MEDLINE]
5.

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.

Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.

PMID:
17408534
[PubMed - indexed for MEDLINE]
Free Article
6.

Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy.

Ots PM, Pérez AR, Carrizosa CL, Ocaña CV, de Dios Sáez Garrido J, Delgado Pérez JM.

Clin Transl Oncol. 2005 Dec;7(11):486-92.

PMID:
16373059
[PubMed - indexed for MEDLINE]
7.

[Guidelines for the treatment of anemia in chronic renal failure].

Triolo G; Italian Society of Nephrology.

G Ital Nefrol. 2003 Sep-Oct;20 Suppl 24:S61-82. Review. Italian.

PMID:
14666504
[PubMed - indexed for MEDLINE]
8.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
9.

Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.

de Castro J, Belda-Iniesta C, Isla D, Dómine M, Sánchez A, Batiste E, Barón MG.

Lung Cancer. 2008 Feb;59(2):211-8. Epub 2007 Sep 17.

PMID:
17875340
[PubMed - indexed for MEDLINE]
10.

Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.

Henry DH.

Drugs. 2007;67(2):175-94. Review.

PMID:
17284083
[PubMed - indexed for MEDLINE]
11.

Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.

Cheer SM, Wagstaff AJ.

Drugs. 2004;64(3):323-46. Review.

PMID:
14871172
[PubMed - indexed for MEDLINE]
12.

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).

Verbeke N, Beguin Y, Wildiers H, Canon JL, Bries G, Bosly A, Van Belle S.

Support Care Cancer. 2012 Jan;20(1):23-8. doi: 10.1007/s00520-010-1045-0. Epub 2010 Nov 25.

PMID:
21107613
[PubMed - indexed for MEDLINE]
13.

Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.

Voravud N, Sriuranpong V.

J Med Assoc Thai. 2005 May;88(5):607-12.

PMID:
16149676
[PubMed - indexed for MEDLINE]
14.

Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.

Biesma B, van de Werf PR, Melissant CF, Brok RG.

Lung Cancer. 2007 Oct;58(1):104-11. Epub 2007 Jun 29.

PMID:
17601632
[PubMed - indexed for MEDLINE]
15.

Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.

Beguin Y.

Med Oncol. 1998 Aug;15 Suppl 1:S38-46. Review.

PMID:
9785336
[PubMed - indexed for MEDLINE]
16.

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.

Borg S, Glenngård AH, Osterborg A, Persson U.

Acta Oncol. 2008;47(6):1009-17. doi: 10.1080/02841860701744498.

PMID:
18770060
[PubMed - indexed for MEDLINE]
17.

Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins.

Oberhoff C.

Support Care Cancer. 2007 Jun;15(6):603-11. Epub 2007 Feb 3. Review.

PMID:
17277926
[PubMed - indexed for MEDLINE]
18.

Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.

Ponchio L, Beguin Y, Farina G, Pedrazzoli P, Pedrotti C, Poggi G, Rosti V, Bergamaschi G, Battistel V, Cazzola M.

Haematologica. 1992 Nov-Dec;77(6):494-501.

PMID:
1289186
[PubMed - indexed for MEDLINE]
19.

[Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].

Haber J, Spicka I, Petruzelka L, Kolesková E, Straub J, Jonásová A, Pospísilová B.

Vnitr Lek. 1996 Apr;42(4):262-7. Czech.

PMID:
8693713
[PubMed - indexed for MEDLINE]
20.

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E.

Cancer. 1995 Dec 1;76(11):2319-29.

PMID:
8635038
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk